SCHEMBL4651817

SCHEMBL4651817

COC(=O)[C@H](Cc1cc(OC(=O)OC(C)(C)C)c(OC(=O)OC(C)(C)C)cc1[Sn](C)(C)C)NC(=O)OC(C)(C)C

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KLK5 Q9Y337 1/20 0.41
TACR1 P25103 2/20 0.40
SCN9A Q15858 2/20 0.39
CYP1A2 P05177 1/20 0.37
CYP2C9 P11712 1/20 0.37
CYP2C19 P33261 1/20 0.37
HTT P42858 1/20 0.37
CTSS P25774 6/20 0.36
CTSK P43235 5/20 0.36
GSTP1 P09211 1/20 0.36
GSTM2 P28161 1/20 0.36
EPHX2 P34913 1/20 0.36
ACE P12821 1/20 0.35
CTSL P07711 3/20 0.35
NFKB1 P19838 1/20 0.35
NFKB2 Q00653 1/20 0.35
RELA Q04206 1/20 0.35
MAPT P10636 1/20 0.35
SMN1; SMN2 Q16637 1/20 0.35
CTSB P07858 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17071630 0.85 KLK5 (0.43) KLK5TACR1SCN9ACYP1A2CYP2C9
SCHEMBL12035787 0.84 MTNR1A (0.46) KLK5TACR1SCN9ACTSSCTSK
SCHEMBL13352198 0.84 MTNR1A (0.46) KLK5TACR1SCN9ACTSSCTSK
SCHEMBL17061439 0.84 MTNR1A (0.46) KLK5TACR1SCN9ACTSSCTSK
SCHEMBL8932203 0.78 SCN9A (0.35) TACR1SCN9ACYP1A2CYP2C9CYP2C19
SCHEMBL29361110 0.77 SCN9A (0.50) TACR1SCN9ACYP1A2CYP2C9CYP2C19
SCHEMBL584547 0.76 SCN9A (0.49) KLK5TACR1SCN9ACYP1A2CYP2C9
SCHEMBL15711996 0.75 KLK5 (0.49) KLK5TACR1CTSSCTSKEPHX2
SCHEMBL8008614 0.75 KLK5 (0.49) KLK5TACR1CTSSCTSKEPHX2
SCHEMBL1571749 0.74 SCN9A (0.47) KLK5TACR1SCN9ACYP1A2CYP2C9

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20150252067-A1 NICKEL FLUORINATING COMPLEXES AND USES THEREOF PRESIDENT AND FELLOWS OF HARVARD COLLEGE (US) 2015-09-10 US disclosed
EP-1697279-B1 RADICAL TRAP IN FLUORIDATION OF IODINIUM SALT GE HEALTHCARE LTD (GB) 2008-09-24 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20150252067-A1 NICKEL FLUORINATING COMPLEXES AND USES THEREOF SLC39A3, SLC39A14, SLC39A7 KLK5 1713/4885TACR1 1930/4885SCN9A 1816/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.